GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Alligator Bioscience AB (STU:7AL) » Definitions » Total Equity

Alligator Bioscience AB (STU:7AL) Total Equity : €-4.50 Mil (As of Mar. 2024)


View and export this data going back to 2021. Start your Free Trial

What is Alligator Bioscience AB Total Equity?

Alligator Bioscience AB's total equity for the quarter that ended in Mar. 2024 was €-4.50 Mil.

This is Residual interest, including minority interest, that remains in the assets of the enterprise after deducting its liabilities. Equity is increased by owners’ investments and by comprehensive income, and it is reduced by distributions to the owners.


Alligator Bioscience AB Total Equity Historical Data

The historical data trend for Alligator Bioscience AB's Total Equity can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Alligator Bioscience AB Total Equity Chart

Alligator Bioscience AB Annual Data
Trend Dec14 Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
Total Equity
Get a 7-Day Free Trial Premium Member Only Premium Member Only 24.67 11.33 27.48 8.10 1.06

Alligator Bioscience AB Quarterly Data
Jun19 Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24
Total Equity Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 2.37 10.44 6.92 1.06 -4.50

Alligator Bioscience AB Total Equity Calculation

Total Equity and Total Liabilities are the two components for Total Assets.

Alligator Bioscience AB's Total Equity for the fiscal year that ended in Dec. 2023 is calculated as

Total Equity=Total Assets(Q: Dec. 2023 )-Total Liabilities(Q: Dec. 2023 )
=10.589-9.529
=1.06

Alligator Bioscience AB's Total Equity for the quarter that ended in Mar. 2024 is calculated as

Total Equity=Total Assets(Q: Mar. 2024 )-Total Liabilities(Q: Mar. 2024 )
=7.756-12.253
=-4.50

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Alligator Bioscience AB Total Equity Related Terms

Thank you for viewing the detailed overview of Alligator Bioscience AB's Total Equity provided by GuruFocus.com. Please click on the following links to see related term pages.


Alligator Bioscience AB (STU:7AL) Business Description

Traded in Other Exchanges
Address
Scheelevagen 2, Medicon Village, Lund, SWE, 223 81
Alligator Bioscience AB is a research-based biotechnology company that develops immune activating antibody drugs for tumor-directed immunotherapy. It is engaged in the development of immunotherapies for the treatment of cancer Its products are ADC-1013, ATOR-1015, and ATOR-1016.

Alligator Bioscience AB (STU:7AL) Headlines

No Headlines